HRSA withdrew its Mega-Guidance from White House review. The Office of Budget and Management announced the action on its Reginfo.gov website. White House review is
Today a federal judge blocked the proposed purchase by Aetna, Inc. of Humana, Inc., holding that the purchase would violate federal antitrust laws. This ruling
Today HRSA published regulations addressing the 340B ceiling price calculations and implementing civil monetary penalties (CMPs) on manufacturers that overcharge covered entities. (more…)
